Lifecore Biomedical CEO: Standalone CDMO Shift Complete, Utilization to Hit 60% by 2029 [Yahoo! Finance]
Lifecore Biomedical, Inc. (LFCR)
Company Research
Source: Yahoo! Finance
completed its transition into a “standalone CDMO” after divesting its former food businesses in 2022 and 2023. Josephs said Lifecore is now focused on two primary operations at its single site in Chaska, Minnesota: hyaluronic acid (HA) fermentation and sterile injectable contract manufacturing. From Landec divestitures to a two-segment CDMO Josephs said Lifecore was previously part of a food conglomerate that traded under the name Landec. The company divested its food businesses—“avocados and salads”—across 2022 and 2023, leaving Lifecore as a life sciences-focused contract development and manufacturing organization. ? Forget Chipmakers: Walmart and Target Are the Real AI Plays He described Lifecore's HA business as rooted in its origins roughly 40 years ago. While hyaluronic acid is widely known for consumer dermatology products, Josephs emphasized Lifecore manufactures “highly sterile injectable grade” HA used in sterile injectable products, primarily for ophthalmic and orth
Show less
Read more
Impact Snapshot
Event Time:
LFCR
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
LFCR alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
LFCR alerts
High impacting Lifecore Biomedical, Inc. news events
Weekly update
A roundup of the hottest topics
LFCR
News
- Lifecore Biomedical (LFCR) was upgraded by Barrington Research from "market perform" to "outperform". They now have a $5.50 price target on the stock.MarketBeat
- Lifecore Biomedical, Inc. (LFCR) Q4 2025 Earnings Call Transcript [Seeking Alpha]Seeking Alpha
- Lifecore targets 12% revenue CAGR through 2029 as midterm pipeline milestones shift [Seeking Alpha]Seeking Alpha
- Lifecore Biomedical Inc (LFCR) Q4 2025 Earnings Call Highlights: Strong Revenue Growth and ... [Yahoo! Finance]Yahoo! Finance
- Lifecore Biomedical Q4 Earnings Call Highlights [Yahoo! Finance]Yahoo! Finance